Therefore, the tumor promoter effects of CCAT2 in ESCC are directed by the CCAT2/miR-200b sponging, which limits the miR-200b levels and inhibitory effect on IGF2BP2. The gene discussed is CCAT2; the disease is esophageal squamous cell carcinoma.